Compare Iamgold Corporation Ordinary Shares (IAG) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iamgold Corporation Ordinary Shares vs State Street SPDR S&P Biotech ETF — how do they compare? Iamgold Corporation Ordinary Shares trades at $18.88 (market cap $10.49B), while State Street SPDR S&P Biotech ETF trades at $153.72 (market cap $10.11B). The key difference: Iamgold Corporation Ordinary Shares and State Street SPDR S&P Biotech ETF are close in size by market cap, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Iamgold Corporation Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iamgold Corporation Ordinary Shares for 1 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| IAG | XBI | |
|---|---|---|
Market Cap | $10.49B | $10.11B |
Volume | 3,160,902 | 12,903,266 |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $24.57 | $169.55 |
52-Week Low | $10.96 | $104.99 |
Typical Hold Time | 1 Days | 38 Days |
Enterprise Value | $10.53B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $153.84, up 2.4% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure offers broad biotech exposure, benefiting from M&A activity and positive clinical catalysts, though key financial ratios are unavailable. Recent news highlights sector optimism driven by cancer vaccine breakthroughs and improved capital access.
Outlook is mixed: bullish sentiment from innovation and M&A supports growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst consensus is neutral (100% Hold), suggesting cautious optimism amid technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Iamgold Corporation Ordinary Shares
IAMGOLD is a gold mining company with operations in Canada. It also explores and develops gold properties.
Read more on IAG →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
